152 related articles for article (PubMed ID: 27709645)
1. Selective plasma exchange can reduce auto-antibodies in patients with bullous pemphigoid without affecting factor XIII and fibrinogen.
Nasu K; Hanafusa N; Nangaku M
J Clin Apher; 2017 Dec; 32(6):589-591. PubMed ID: 27709645
[TBL] [Abstract][Full Text] [Related]
2. Selective plasma exchange.
Ohkubo A; Okado T
Transfus Apher Sci; 2017 Oct; 56(5):657-660. PubMed ID: 28939369
[TBL] [Abstract][Full Text] [Related]
3. Selective Plasma Exchange for the Removal of Pemphigus Autoantibodies, Fibrinogen, and Factor XIII in Pemphigus Vulgaris.
Miyamoto S; Ohkubo A; Seshima H; Komori S; Yamamoto M; Maeda T; Itagaki A; Yamamoto H; Nojima K; Iimori S; Naito S; Kurashima N; Sohara E; Rai T; Uchida S; Okado T
Ther Apher Dial; 2017 Jun; 21(3):226-231. PubMed ID: 28661086
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid.
Mersmann M; Dworschak J; Ebermann K; Komorowski L; Schlumberger W; Stöcker W; Zillikens D; Probst C; Schmidt E
Arch Dermatol Res; 2016 Jan; 308(1):31-8. PubMed ID: 26498290
[TBL] [Abstract][Full Text] [Related]
6. Reducing Fibrinogen and Factor XIII Using Double-Filtration Plasmapheresis for Antibody-Mediated Rejection: Predictive Models.
Jouve T; Marlu R; Malvezzi P; Seyve L; Maurizi J; Carron PL; Polack B; Rostaing L
Blood Purif; 2018; 46(3):239-245. PubMed ID: 29972828
[TBL] [Abstract][Full Text] [Related]
7. Double filtration plasmapheresis can decrease factor XIII Activity.
Hanafusa N; Kondo Y; Suzuki M; Nakao A; Noiri E; Fujita T
Ther Apher Dial; 2007 Jun; 11(3):165-70. PubMed ID: 17497996
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
9. Removal Dynamics of Immunoglobulin and Fibrinogen by Conventional Plasma Exchange, Selective Plasma Exchange, and a Combination of the Two.
Miyamoto S; Ohkubo A; Seshima H; Maeda T; Itagaki A; Kurashima N; Iimori S; Naito S; Sohara E; Rai T; Uchida S; Okado T
Ther Apher Dial; 2016 Aug; 20(4):342-7. PubMed ID: 27523073
[TBL] [Abstract][Full Text] [Related]
10. Virus removal and eradication by modified double filtration plasmapheresis decreases factor XIII levels.
Hanafusa N; Satonaka H; Doi K; Noiri E; Fujita T
Ther Apher Dial; 2010 Jun; 14(3):287-91. PubMed ID: 20609180
[TBL] [Abstract][Full Text] [Related]
11. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
12. Double filtration plasmapheresis for the treatment of bullous pemphigoid: a three case report.
Kitabata Y; Sakurane M; Orita H; Kamimura M; Siizaki K; Narukawa N; Kaketaka A; Abe T; Kobata H; Akizawa T
Ther Apher; 2001 Dec; 5(6):484-90. PubMed ID: 11800086
[TBL] [Abstract][Full Text] [Related]
13. Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption.
Herrero-González JE; Sitaru C; Klinker E; Bröcker EB; Zillikens D
Clin Exp Dermatol; 2005 Sep; 30(5):519-22. PubMed ID: 16045683
[TBL] [Abstract][Full Text] [Related]
14. The impact of therapeutic plasma exchange and double filtration plasmapheresis on hemostasis in renal transplant recipients.
Vatazin AV; Zulkarnaev AB
Ter Arkh; 2018 Jun; 90(6):22-27. PubMed ID: 30701900
[TBL] [Abstract][Full Text] [Related]
15. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
[TBL] [Abstract][Full Text] [Related]
16. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.
Iwata Y; Komura K; Kodera M; Usuda T; Yokoyama Y; Hara T; Muroi E; Ogawa F; Takenaka M; Sato S
Arch Dermatol; 2008 Jan; 144(1):41-8. PubMed ID: 18209167
[TBL] [Abstract][Full Text] [Related]
17. Childhood bullous pemphigoid: clinical and immunological findings in a series of 4 cases.
Martinez-De Pablo MI; González-Enseñat MA; Vicente A; Gilaberte M; Mascaró JM
Arch Dermatol; 2007 Feb; 143(2):215-20. PubMed ID: 17310001
[TBL] [Abstract][Full Text] [Related]
18. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A
Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658
[TBL] [Abstract][Full Text] [Related]
19. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
[TBL] [Abstract][Full Text] [Related]
20. Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid.
Ahmadpoor P; Beck M; Michel M; Pambrun E; Stoebner P; Moranne O
J Clin Apher; 2024 Jun; 39(3):e22133. PubMed ID: 38881050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
